Business & FinanceTop StoryTop StoryLatest News
Alkem Lab Q2 profit falls 14.4% to ₹667 cr; revenue rises to ₹4,552 cr
Sentiment: NeutralHigh Priority
What Happened?
Alkem Laboratories reported a 14.37% decline in net profit to ₹667.13 crore for Q2 FY27, despite a revenue increase to ₹4,551.99 crore. Total expenses rose significantly during the quarter.
Key points
- Net profit fell to ₹667.13 crore from ₹779.11 crore year-on-year.
- Revenue from operations increased to ₹4,551.99 crore from ₹4,000.99 crore.
- Total expenses rose to ₹3,721.55 crore from ₹3,208.85 crore.
- India business revenue grew 9.5% to ₹3,027.5 crore.
- International business revenue increased 22.3% to ₹1,454 crore.
- Alkem expanded its MedTech presence with Occlutech.
Key insights
- The decline in profit may prompt Alkem to reassess its cost management strategies.
- Continued revenue growth in the India business could enhance market confidence.
- The international business's performance amidst pricing pressure highlights resilience.
Why it matters
The financial performance indicates challenges in profitability despite revenue growth.
Tags
Entities
Alkem Laboratories· CompanySandeep Singh· Person
Source
Business Standard
